What is Regeneron Pharmaceuticals's maturities after five years?

Regeneron Pharmaceuticals (REGN) reported maturities after five years of $98.40M in Q1 2026.

What is the long-term trend for Regeneron Pharmaceuticals's maturities after five years?

Over 3 years (2022 to 2025), Regeneron Pharmaceuticals's maturities after five years has grown at a 55.4% compound annual growth rate (CAGR), from $400.00K to $1.50M.

Other

Maturities after five years

Regeneron Pharmaceuticals Maturities after five years increased by 6460.0% to $98.40M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Maturities after five years shows an upward trend with a 55.4% CAGR.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ4 2019

Last reportedQ1 2026

Metric ID: other_debt_securities_available_for_sale_fair_value_matu_2cdf87

Historical Data

13 periods

	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$400.00K	$11.30M	$9.80M	$4.40M	$4.60M	$13.40M	$0.00	$800.00K	$0.00	$400.00K	$66.00M	$1.50M	$98.40M
QoQ Change	—	>999%	-13.3%	-55.1%	+4.5%	+191.3%	-100.0%	—	-100.0%	—	>999%	-97.7%	>999%
YoY Change	—	—	—	—	>999%	+18.6%	-100.0%	-81.8%	-100.0%	—	>999%	—	—

Range$0.00 – $98.40M

CAGR+526.6%

Avg YoY Growth>999%

Median YoY Growth-31.6%

Frequently Asked Questions

What is Regeneron Pharmaceuticals's maturities after five years?: Regeneron Pharmaceuticals (REGN) reported maturities after five years of $98.40M in Q1 2026.
What is the long-term trend for Regeneron Pharmaceuticals's maturities after five years?: Over 3 years (2022 to 2025), Regeneron Pharmaceuticals's maturities after five years has grown at a 55.4% compound annual growth rate (CAGR), from $400.00K to $1.50M.